NanoMediTech’s project of interest is located near Cabo Delgado, which is known for its resources and natural flake graphite and the surrounding area also contains high-grade graphite deposits.

NanoMediTech’s Chief Financial Officer, Mr. Yie Seong-ho commented on the joint venture saying “This joint venture is a positive move for us as Mozambique is an African leader in minerals. Our investment will also benefit the local area in terms of jobs and income and industry. Having a deposit is key to building a successful vertically integrated graphite company with the best resources. This project will provide NanoMediTech with an additional reliable graphite source which will incur less manufacturing costs.”

“Over the last few years, NanoMediTech has been working relentlessly to understand the global and specific graphite requirements. We have spent considerable time and money in researching and developing unique graphite products this has provided the company with a detailed and thorough understanding of the requirements and opportunities in the graphite world. Our Mozambique project has an open pit high-grade deposit in a mining friendly jurisdiction reducing the time to mine the graphite,” added Yie Seong-ho, Chief Financial Officer of NanoMediTech.

About Us - NanoMediTech

Based in Seoul, Republic of Korea, NanoMediTech is a research and development company developing nanotechnology based biomedical applications. The company is leveraging its proprietary nanotechnologies to develop radically improved medical tools and solutions for the treatment of debilitating diseases and improvement of medical practices.

Nanotechnology is a burgeoning industry with practically limitless applications on our lives and with the potential to revolutionize the manner in which we detect and treat diseases and damage to the human body.